While Myc is one of the most implicated oncoproteins in human cancer [27,28,29,30], its pathogenetic roles in ALK+ALCL have not been well-defined, although a handful of previous studies have shown that Myc is a downstream target of NPM-ALK via STAT3 signaling [31,32]. This evidence concerns the gene NPM1 and cancer.